| [1] |
Reinhardt M, Beu M, Vosberg H, et al. Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET[J]. J Nucl Med, 1999, 40:977-985.
|
| [2] |
Wahl LM, Asselin MC, Nahmias C. Regions of interest in the venous sinuses as input functions for quantitative PET[J]. J Nucl Med, 1999,40:1666-1675.
|
| [3] |
Wakita K, Imahori Y, Ido T, et al. Simplification for measuring input function of FDG PET:investigation of 1-point blood sampling method[J]. J Nucl Med, 2000, 41:1484-1490.
|
| [4] |
Shiozaki T, Sadato N, Senda M, et al. Noninvasive estimation of FDG input function for quantification of cerebral metabolic rate of glucose:optimization and multicenter evaluation[J]. J Nucl Med, 2000, 41:1612-1618.
|
| [5] |
Philips RL, Chen CY, Wong DF, et al. An improved method to calculate cerebral metabolic rates of glucose using PET[J]. J Nucl Med, 1995, 36:1668-1679.
|
| [6] |
Oehr P, Biersack HJ. PET in oncology:basics and clinical applications[M]. Berlin:Springer, 2000. 45-47.
|
| [7] |
Graham MM, Muzi M, Spence AM, et al. The FDG lumped constant in normal human brain[J]. J Nucl Med, 2002, 43:1157-1166.
|
| [8] |
Hasselbalch SG, Holm S, Pedersen HS, et al. The (18)F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose[J]. J Cereb Blood Flow Metab, 2001, 21:995-1002.
|
| [9] |
Botker HE, Bottcher M, Schmitz O, et al. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose[J]. J Nucl Cardiol,1997, 4:125-132.
|
| [10] |
Ng CK, Soufer R, McNulty PH. Effect of hyperinsulinemia on myocardial fluore-18-FDG uptake[J]. J Nucl Med, 1998,39:379-383.
|
| [11] |
Wiggers H, Bottcher M, Nielsen TT, et al. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy:application of a new quantitative method using regional tracer kinetic information[J]. J Nucl Med, 1999,40:1292-1300.
|
| [12] |
Nuutila P, Kinisto VA, Knwuti J, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo[J].J Clin Ivest, 1992, 89:1767-1774.
|
| [13] |
Kelley DE, Williams KV, Price JC, et al. Determination of the lumped constant for [18F]fluorodeoxyglucose in human skeletal muscle[J]. J Nucl Med, 1999, 40:1798-1804.
|
| [14] |
Peltoniemi P, Lonnroth P, Laine H, et al. Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans[J]. Am J Physiol Endocrinol Metab.2000, 279:E1122-E1130.
|
| [15] |
Kuwabara H, Evans AC, Gjedde A. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose[J]. J Cereb Blood Flow Metab, 1990, 10:180-189.
|
| [16] |
Botker HE, Goodwin GW, Holden JE, et al. Myocardial glucose uptake measured with fluorodeoxyglucose:a proposed method to account for variable lumped constants[J]. J Nucl Med, 1999, 40:1186-1196.
|